RHSC Protocol 8.1 CRYOTHERAPY TO WARTS PROTOCOL RHSC PROTOCOL 8.1 Yorkhill Division Nursing and Midwifery Policy committee Policy Number: RHSC PROTOCOL 8.1 Policy Name: CRYOTHERAPY TO WARTS Personnel policy applies to This policy applies to all registered nurses working within the dermatology nursing service within the Yorkhill Division of NHS Greater Glasgow. STATEMENT As a registered nurse, the designated nurse is personally accountable for his/her own practice and in exercising accountability may therefore enhance his/her own skills by performing cryotherapy to warts. This document authorises cryotherapy treatment by the defined group of nursing staff who meet the criteria for the inclusion under the terms of the document. 1.0 Protocol The designated nurse will work in partnership with dermatology medical staff, and will at all times assess and prioritise duties, seeking the co-operation of medical staff when necessary to ensure patients needs are met. 2.0 Characteristics of the Nurse Performing Cryotherapy The designated nurse will be deemed competent by: Receiving in house theoretical and practical training and assessment from dermatology sister/consultant, achieving at least level 5 competency (See attached training pack). Observing at least five patients diagnosed as having warts being treated with liquid nitrogen. Subsequently, the designated nurse should have competently treated a minimum of five patients with facial warts in addition to five other patients with hand and foot warts under supervision. Demonstrating capabilities with regard to safe and competent practice and agreeing to continuous assessment with regards to wart cryotherapy. Completing a “Record of Practice Development” form with evidence of at least yearly reviews. The designated nurse must adhere to the following: NMC Code of professional conduct (2004) NMC Scope of professional practice (2002) NMC Guidelines for the administration of medicines (2004) NMC Guidelines for records and record keeping (2004) NHS Greater Glasgow Standard Precautions Policy (2005) NHS Greater Glasgow Clinical Waste Disposal Policy (2005) Yorkhill Division Outpatient Department guidelines on the safe handling and storage of liquid nitrogen (2003) Control of Substances Hazardous to Health regulations (1994) Children (Scotland) Act (1995) HMSO Age of Legal Capacity Act (1991) HMSO Data Protection Act (1998) 1 RHSC PROTOCOL 8.1 3.0 Conditions Under Which the Protocol Can be Used Criteria for Inclusion Patient presenting with viral warts diagnosed and referred by a medical practitioner. Patient wishing and allowing treatment to be carried out, written consent must be obtained. Criteria for Exclusion Patient referred by nursing staff Patient not wishing or allowing treatment to be carried out Good Practice Guidelines for Cryotherapy to Warts are attached for reference and to enhance the safety and quality of practice. 4.0 Supporting Literature Champion RH, Burton JL, Ebling FJG (1993) Textbook of Dermatology Volume 2 5th Edition Blackwell scientific Publications Oxford Dawber R, Colver G, Jackson A (1997) Cutaneous Cryosurgery: Principles and Clinical Practice 2nd Edition Dunitz London Kuwahara RT (2003) Cryotherapy www.emedicine.com/derm (accessed 04/11/03) 5.0 Authors Lizanne McInnes, Dermatology Sister Anne Speirs, Dermatology Sister 6.0 Ratification Director of Nursing and Patient Services Signature: _____________________________________ Date: _____________________________________ October 2005 Review Date October 2007 2 CRYOTHERAPY TO WARTS TEACHING PACKAGE 3 CONTENTS Page 2 Aims and Objectives 3 Human Papilloma Virus (HPV) Types of Wart 4 Viabilty, Transmission, Treatment 5 Home Treatment 6 Cryotherapy Treatment Liquid Nitrogen and Cell Interaction 7 Side Effects and Complications 8 Hazards Associated with Liquid Nitrogen Hazards (cont) 9 Competencies for Performing Cryotherapy 10 Competencies (cont) 11 Assessment Criteria 12 Assessment 13 Record of Supervised Practice 14 Record of Supervised Practice (cont) 15 Record of Assessment and Training 4 AIMS AND OBJECTIVES Aim To provide a core knowledge in the treatment of warts using liquid nitrogen. Objectives - To develop an understanding of the wart virus. - To understand first line treatment of warts. - To understand the principles of cryotherapy and tissue interactions. - To understand the hazards associated with the use if liquid nitrogen. - To understand the risks, benefits, possible complications and side effects associated with liquid nitrogen. - To be able, after study of the above issues, to answer the theoretical sections of the liquid nitrogen competency assessment. 5 Wart Biology Human Papilloma Virus HPV) Warts are benign epidermal tumors produced by the human papillomavirus (HPV) infection of the skin and mucous membranes. There are around 60 different types of HPV that cause warts, each type preferring a specific skin location. In children they are seen most commonly on the fingers, hands, feet and face but can appear anywhere on the body. Types of wart Common wart: a firm raised lump with a rough surface. Often seen in isolation or in clumps on the knuckles, knees and nail folds. Plantar wart: affect the soles of the feet, commonly called verrucas. Periungual wart: affect under and around the nails. Filiform wart: long, slender growths on lips, eyelids, face or neck. Plane wart:: smooth, flat topped or slightly raised, affecting face or back of hands. Mosaic wart: this is a collection of small warts grouped together in a cluster. Genital wart: these are warts affecting the genital area and can be sexually transmitted but not always. Can also be passed from mother to baby during delivery if mum has vaginal papillomavirus infection at time of delivery. 6 Viability Heating to temperatures above 55°c inactivates the virus. The virus can be stored at -25°c for many months without losing its activity. The incubation period varies from 1 to 3 months and possibly up to several years. Transmission Warts are spread by direct or indirect contact. Impairment of the epithelial barrier function, by trauma (including mild abrasions), maceration or both, greatly predisposes the individual to inoculation of the virus, and is generally assumed to be required for infection at least in fully keratinisied skin. Warts can also spread on the same person. Proximity of other warts is important, new warts occur more readily in areas with warts present than without. Whether a wart will develop as a result of inoculation with infected materials will depend on the amount of virus present and the immunity of the individual towards the virus. Treatment Routine treatment of warts is not necessary. They are harmless and do not compromise the patients’ health. Most will resolve spontaneously without trace within 6 –18 months, although some patients’ warts can present for 3 – 5 years and in a minority of patients they can persist for longer. 7 Home Treatment Patients should be informed about their condition and advised on how to reduce the risk of cross infection. Once they have a basic understanding of the virus the more likely they are to be successful in treating it successfully. Treatment of warts at home is time consuming and requires perseverance and commitment from the patient. Topical treatments used contain salicylic acid and should be applied every night for up to 12 weeks. Salicylic acid works by destroying the keratin that makes up the wart. These treatments should not be used on the face or genital area, as irritation is likely. Filing down the hyperkeratotic wart is essential as this enables the topical treatment to penetrate the epidermis and reach the wart virus. The gentle use of a pumice stone or emery board is helpful in the removal of the surface keratin. However over enthusiastic abrasion is common and may enhance the spread of the virus by inoculation into adjacent skin. It is also thought that the gentle abrasion of the skin when removing the keratin may also stimulate an immune response to the virus. An accurate application of salicylic acid preparation is essential to avoid damaging normal skin. This can be achieved by using a fine applicator or protecting the surrounding skin with vaseline. If topical treatment comes into contact with healthy skin surrounding the wart it can cause irritation. Stopping application for a few nights and being more careful when applying the solution can usually control this. Penetration into thick keratin, such as that on the sole of the foot, can be enhanced by occlusion, which promotes maceration of the keratin layer and reduction of the barrier function. 8 Salicylic acid preparations should be used for at least 3 months, if this is ineffective treatment with liquid nitrogen may be considered as the next stage depending on the age of the child and their level of understanding. Cryotherapy Treatment using Liquid Nitrogen The goal of cryotherapy is to freeze and destroy unwanted targeted skin growths e.g warts, while preserving the surrounding skin. Liquid nitrogen is a second line treatment used to treat warts if topical treatments have been unsuccessful or as a first line treatment for facial and genital warts. Treatment is repeated every 3 weeks for 10 treatments, this allows any inflammation from the previous treatment to resolve. If treatment is reduced to 4 weekly or longer the cure rate drops dramatically and the treatment becomes much less effective, therefore regular attendance is essential. Liquid Nitrogen and Cell Interaction Extra circular ice damages cell membranes. Intra circular ice also forms in many cells during freezing and is thought to damage mitochondria and endoplasmic reticulum. Large ice crystals are more damaging than small ones. Slow thawing is associated with re-crystallisation of ice and this approach is known to be more destructible that rapid thawing. An immune response to the wart virus develops in patients whose warts have been treated with several cryotherapy treatments. Destruction of the tissue does not effect a cure unless the virus is also eradicated, so this immunological response is important. 9 Side Effects and Complications Associated with Liquid Nitrogen Treatment Pain and Inflammation: whilst warts are being frozen the patient will experience a burning sensation. As the wart thaws out it begins to throb and continues to do so for a variable time. The degree and duration of discomfort depends on the length of freeze and the patients’ level of pain tolerance. A simple analgesia such as paracetamol is recommended if pain persists. Blistering: water blisters or occasionally haemorrhagic blisters may develop within a day or two. These can be punctured using a sterile needle and the fluid drained to reduce pain and discomfort. Pigmentary Changes: Hypopigmentation of the area treated can occur, more common in darkly pigmented patients. Hyperpigmentation can also occur. Both generally only last for a few months, but can be longer lasting. Nerve Damage: this is possible but rare, particularly in areas where the nerves lie close to the surface of the skin, such as sides of the fingers, the wrists and the area behind the ears. It has been reported that this will resolve within a few months. Hazards Associated with Liquid Nitrogen Liquid nitrogen boils at - 196°c and will explode if kept in a totally sealed container, the storage vessel is designed to allow some evaporation. The main hazard to the practitioner is when decanting from the storage unit to the flask. 10 When decanting liquid nitrogen from the storage vessel: - Protective clothing must be worn: specialist gloves are worn to prevent frost burns and goggles must be worn due to the risk of splashing. - The room must be well ventilated as liquid nitrogen forms an oxygen deficient atmosphere. The Yorkhill Division Outpatient Department ‘Guidelines on the Safe handling and Storage of Liquid Nitrogen’ must be adhered to at all times. 11 Competencies for Performing Cryotherapy Theoretical Competencies The nurse will: 1. Demonstrate knowledge of various types of warts and their biology 2. Demonstrate knowledge of mode of transmission and virus viability. 3. Describe with understanding first line treatments and their effectiveness. 4. Discuss the possible complications and side effects of cryotherapy. 5. Discuss the safety issues involved with cryotherapy treatment and describe the care that must be taken with liquid nitrogen. Practical Competences The nurse will: 1. Competently and safely fill Cryovac ® from the storage vessel. 2. Is able to select the appropriate method to treat wart depending on body site. 3. Effectively prepare the patient physically and psychologically for cryotherapy treatment. 4. Manual dexterity when performing treatment. 5. Advise the patient on the appropriate after care required and inform them of any possible side effects. Provides patient with patient information leaflet on cryotherapy. 6. Accurately document the treatment and any improvement or deterioration in the patients medical notes. 7. Recognise and discuss the main side effects and complications of treatments (topical and cryotherapy). 8. Make appropriate referral to medical staff in the event of any complications or treatment being unsuccessful. 9. Demonstrate organisational awareness by good time management of lists and ensuring all equipment required for cryotherapy is available. Lizanne McInnes - Dermatology Sister (April 2005) 12 ASSESSMENT CRITERIA LEVEL OF ACHIEVEMENT Novice Cannot perform this activity Can perform this task but not without constant supervision and assistance Advanced Beginner Can perform this activity satisfactorily but requires some supervision and assistance. Competent Can perform this activity satisfactorily without supervision or assistance. Can perform this activity satisfactorily without supervision or assistance with more than acceptable speed and quality of work. Proficient Expert Can perform this activity satisfactorily with more than acceptable speed and quality and with initiative and adaptability to special problem situations. Can perform this activity with more than acceptable speed and quality, with initiative and adaptability and can lead others in performing this task. 13 GRADE 0 1 2 3 4 5 6 ASSESSMENT Theoretical Competencies No 1. 0 1 2 3 4 5 6 No 2. 0 1 2 3 4 5 6 No 3. 0 1 2 3 4 5 6 No 4. 0 1 2 3 4 5 6 No 5. 0 1 2 3 4 5 6 Circle appropriate score Practical Competencies No 1. 0 1 2 3 4 5 6 No 2. 0 1 2 3 4 5 6 No 3. 0 1 2 3 4 5 6 No 4. 0 1 2 3 4 5 6 No 5. 0 1 2 3 4 5 6 No 6. 0 1 2 3 4 5 6 No 7. 0 1 2 3 4 5 6 No 8. 0 1 2 3 4 5 6 Circle appropriate score Date of assessment : …………………………………………………… Signature of supervisor: ………………………………………………... 14 RECORD OF SUPERVISED ASSESSMENT AND PRACTICE The dermatology sister or consultant will demonstrate at least five patients diagnosed as having warts being treated with liquid nitrogen. Following this the designated nurse will competently treat a minimum of five patients with facial warts, five patients with hand warts, five patients with plantar warts and five patients with genital warts under supervision adhering to the Cryotherapy Good Practice Guidelines. Hand warts Supervisors signature Date Attempt 1 ………………………………….. ……………………. Attempt 2 ………………………………….. ……………………. Attempt 3 ………………………………….. ……………………. Attempt 4 ………………………………….. ……………………. Attempt 5 ………………………………….. ……………………. Plantar warts Supervisors signature Attempt 1 ………………………………….. ……………………. Attempt 2 ………………………………….. ……………………. Attempt 3 ………………………………….. ……………………. Attempt 4 ………………………………….. ……………………. Attempt 5 ………………………………….. ……………………. 15 Facial warts Supervisors signature Date Attempt 1 ………………………………….. ……………………. Attempt 2 ………………………………….. ……………………. Attempt 3 ………………………………….. ……………………. Attempt 4 ………………………………….. ……………………. Attempt 5 ………………………………….. ……………………. Genital warts Supervisors signature Date Attempt 1 ………………………………….. ……………………. Attempt 2 ………………………………….. ……………………. Attempt 3 ………………………………….. ……………………. Attempt 4 ………………………………….. ……………………. Attempt 5 ………………………………….. ……………………. 16 RECORD OF ASSESSMENT AND TRAINING FOR ADVANCED PRACTICE SKILLS ……………………………………………………………………………………………… has had the appropriate training and supervision and has been deemed competent to perform cryotherapy to warts. ASSESSORS SIGNATURE DATE ………………………………………… ………………………. PRACTITIONERS SIGNATURE DATE ………………………………………… ………………………. 17